Black-market vaping has made the entire cannabis group toxic.
What is the green swan that will bring buyers back to cannabis companies?
I'm considering establishing a long investment stake in a package of cannabis stocks, with emphasis on U.S.-based companies.
This looks like a good opportunity to take a fresh look at the charts and indicators of the former 'high flyer'.
After a negative report on GW's epilepsy treatment, the analyst refused to explain the results with me, bringing more questions than answers about its conclusions.
Shares of the cannabinoid prescription medicine company look to be in a weak state.
Let's go to the charts and indicators.
Shares of the cannabis company are likely to drift lower in the weeks ahead.
Singer teamed up with company this week, sending its stock on a wild ride.
A cautious approach by the state is having a wicked effect on earnings and estimates.